Research Article
Risk Factors Associated with Acute Sarcopenia in Patients Hospitalized with COVID-19
Table 3
Association between acute sarcopenia and outcomes.
| Variables | Acute sarcopenia | OR (95%CI) | value | Yes (n = 34) | No (n = 179) |
| Male (%) | 55.9 | 65.4 | 7 (0.32–1.41) | 0.292 | Elderly (%) | 73.5 | 37.4 | (2.0–10.5) | <0.001 | Comorbidities (%) | Obesity | 8.8 | 32.4 | (1.45–16.9) | 0.005 | Arterial hypertension | 47.1 | 45.8 | 5 (0.45–1.98) | 0.893 | Diabetes mellitus | 29.4 | 26.3 | 5 (0.38–1.92) | 0.703 | Signs and symptoms of prehospitalization (%) | Myalgia | 50 | 36.9 | 8 (0.28–1.2) | 0.150 | Fever | 47.1 | 57 | (0.71–3.1) | 0.286 | Dyspnea | 50 | 45.3 | 2 (0.4–1.7) | 0.611 | Asthenia | 44.1 | 44.7 | 2 (0.49–2.1) | 0.951 | Anorexia | 100 | 87.2 | 7(0.82–0.92) | 0.027 | Dysgeusia/dysosmia/anosmia | 29.4 | 34.1 | 4 (0.56–2.76) | 0.597 | Vomitus | 29.4 | 17.9 | 2 (0.23–1.2) | 0.121 | Diarrhea | 32.4 | 25.1 | 2 (0.32–1.55) | 0.381 | Unintentional weight loss (%) | 97.1 | 89.4 | 5 (0.03–2.00) | 0.160 | Percentage of unintentional weight loss ≥3% (%) | 81.1 | 35 | (3.2–21.4) | <0.001 | Nutritional therapy (%) | 79.4 | 45.5 | (1.9–11.2) | <0.001 | Death (%) | 17.6 | 16.2 | (0.42–2.91) | 0.835 |
|
|
OR = odds ratio; CI = confidence interval. Statistic presented: number and percentage. Statistical test performed: chi-square test.
|